Chris Murphy actually said...
If we are successful in getting this pathway to biosimilars moving then my fear is with a product sitting on the market that could cost 30 percent less we are going to be behind this avalanche of pharmaceutical advertising that will keep the market away from the biosimilars.
Context
Senator Murphy expresses concern over pharmaceutical advertising hindering biosimilar adoption.
09/16/2015